We are live on ! Find out more
SIS

Susquehanna International Securities Portfolio holdings

AUM $422M
1-Year Est. Return 4.92%
This Fund
S&P 500
This Quarter Est. Return
+21.37%
1 Year Est. Return
-4.92%
3 Year Est. Return
+2.8%
5 Year Est. Return
+42.56%
10 Year Est. Return
AUM
$138M
AUM Growth
-$52M
Cap. Flow
-$78.9M
Cap. Flow %
-57.3%
Top 10 Hldgs %
66.78%
Holding
60
New
9
Increased
5
Reduced
13
Closed
19

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$14.6M
2
NVS icon
Novartis
NVS
+$10.4M
3
HSBC icon
HSBC
HSBC
+$9.58M
4
ING icon
ING
ING
+$5.82M
5
STLA icon
Stellantis
STLA
+$3.52M

Sector Composition

Rank Sector Weight
1 Healthcare 22.99%
2 Energy 14.9%
3 Financials 13.57%
4 Communication Services 4.88%
5 Utilities 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STLA icon
1
CALL
Stellantis
STLA
$21.7B
$14.5M 10.52%
800,800
AZN icon
2
AstraZeneca
AZN
$263B
$13.7M 9.98%
+137,483
New +$14.6M
NVS icon
3
Novartis
NVS
$297B
$11.2M 8.15%
+118,837
New +$10.4M
HSBC icon
4
HSBC
HSBC
$365B
$10.4M 7.59%
+403,035
New +$9.58M
TS icon
5
Tenaris
TS
$28.9B
$9.53M 6.93%
597,731
-133,345
-18% -$1.78M
VOD icon
6
CALL
Vodafone
VOD
$36.3B
$7.54M 5.48%
457,600
NGG icon
7
National Grid
NGG
$80.4B
$6.67M 4.85%
127,867
-22,615
-15% -$1.2M
ING icon
8
ING
ING
$99.8B
$6.41M 4.65%
+678,700
New +$5.82M
WPP icon
9
WPP
WPP
$4.36B
$6.39M 4.64%
118,187
NVO
10
CALL
Novo Nordisk
NVO
$208B
$5.49M 3.99%
157,200
NVO
11
PUT
Novo Nordisk
NVO
$208B
$5.18M 3.76%
148,200
RDS.B
12
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$5.09M 3.7%
151,480
-874,974
-85% -$26M
LIN icon
13
Linde
LIN
$221B
$4.35M 3.16%
16,500
-7,500
-31% -$1.84M
STLA icon
14
Stellantis
STLA
$21.7B
$4.33M 3.14%
+239,127
New +$3.52M
CMBT
15
CMB.TECH NV
CMBT
$4.69B
$2.84M 2.07%
355,500
+50,000
+16% +$409K
CS
16
DELISTED
Credit Suisse Group
CS
$2.54M 1.85%
198,426
-119,733
-38% -$1.39M
SNY icon
17
Sanofi
SNY
$103B
$2.29M 1.66%
+47,146
New +$2.33M
LKFT
18
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
$2.15M 1.56%
21,700
+9,500
+78% +$1.16M
GRFS
19
Grifois
GRFS
$5.36B
$2.04M 1.48%
110,363
+5,000
+5% +$92.7K
BTI icon
20
British American Tobacco
BTI
$131B
$1.64M 1.19%
+43,745
New +$1.57M
FTI icon
21
TechnipFMC
FTI
$28.1B
$1.55M 1.13%
221,580
+31,450
+17% +$185K
RDS.A
22
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.5M 1.09%
42,656
-445,224
-91% -$13.9M
CCL icon
23
Carnival Corporation Ltd
CCL
$38.1B
$1.25M 0.91%
57,800
+24,600
+74% +$437K
NWG icon
24
NatWest
NWG
$75.4B
$971K 0.71%
199,457
NVS icon
25
CALL
Novartis
NVS
$297B
$944K 0.69%
10,000
-20,000
-67% -$1.75M

Similar funds

Susquehanna International Securities's Q4 2020 Portfolio in Review

As of Q4 2020, Susquehanna International Securities held 60 positions worth $138M, down 27% from $190M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Susquehanna International Securities withdrew a net $78.9M in Q4 2020, closing 19 positions and reducing 13 holdings. Its most notable exit was ASML, an estimated $11.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 4.4% a quarter earlier, followed by Energy and Financials.

Against the trend, Susquehanna International Securities opened a new position in AstraZeneca worth $13.7M.

  • Susquehanna International Securities's largest Q4 2020 buy was AstraZeneca: 137,483 shares worth $13.7M.
  • Susquehanna International Securities added most to Lakefront Biotherapeutics American Depositary Shares in Q4 2020, an estimated $1.16M increase.
  • Susquehanna International Securities's biggest Q4 2020 reduction was Nokia, cutting an estimated $30.3M.
  • Susquehanna International Securities fully exited ASML in Q4 2020, selling an estimated $11.3M.
  • Susquehanna International Securities's ten largest holdings make up 67% of its $138M portfolio in Q4 2020.
  • Susquehanna International Securities opened 9 new positions and closed 19 in Q4 2020.
  • Susquehanna International Securities's portfolio value fell 27% quarter-over-quarter to $138M.

Based on Susquehanna International Securities's 13F filing for Q4 2020, filed 16 Feb 2021.